Skip to main content
Journal cover image

Imaging tumor hypoxia to advance radiation oncology.

Publication ,  Journal Article
Lee, C-T; Boss, M-K; Dewhirst, MW
Published in: Antioxid Redox Signal
July 10, 2014

SIGNIFICANCE: Most solid tumors contain regions of low oxygenation or hypoxia. Tumor hypoxia has been associated with a poor clinical outcome and plays a critical role in tumor radioresistance. RECENT ADVANCES: Two main types of hypoxia exist in the tumor microenvironment: chronic and cycling hypoxia. Chronic hypoxia results from the limited diffusion distance of oxygen, and cycling hypoxia primarily results from the variation in microvessel red blood cell flux and temporary disturbances in perfusion. Chronic hypoxia may cause either tumor progression or regressive effects depending on the tumor model. However, there is a general trend toward the development of a more aggressive phenotype after cycling hypoxia. With advanced hypoxia imaging techniques, spatiotemporal characteristics of tumor hypoxia and the changes to the tumor microenvironment can be analyzed. CRITICAL ISSUES: In this review, we focus on the biological and clinical consequences of chronic and cycling hypoxia on radiation treatment. We also discuss the advanced non-invasive imaging techniques that have been developed to detect and monitor tumor hypoxia in preclinical and clinical studies. FUTURE DIRECTIONS: A better understanding of the mechanisms of tumor hypoxia with non-invasive imaging will provide a basis for improved radiation therapeutic practices.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Antioxid Redox Signal

DOI

EISSN

1557-7716

Publication Date

July 10, 2014

Volume

21

Issue

2

Start / End Page

313 / 337

Location

United States

Related Subject Headings

  • Radiation Oncology
  • Neoplasms
  • Molecular Imaging
  • Humans
  • Cell Hypoxia
  • Biochemistry & Molecular Biology
  • 3205 Medical biochemistry and metabolomics
  • 3101 Biochemistry and cell biology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1101 Medical Biochemistry and Metabolomics
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Lee, C.-T., Boss, M.-K., & Dewhirst, M. W. (2014). Imaging tumor hypoxia to advance radiation oncology. Antioxid Redox Signal, 21(2), 313–337. https://doi.org/10.1089/ars.2013.5759
Lee, Chen-Ting, Mary-Keara Boss, and Mark W. Dewhirst. “Imaging tumor hypoxia to advance radiation oncology.Antioxid Redox Signal 21, no. 2 (July 10, 2014): 313–37. https://doi.org/10.1089/ars.2013.5759.
Lee C-T, Boss M-K, Dewhirst MW. Imaging tumor hypoxia to advance radiation oncology. Antioxid Redox Signal. 2014 Jul 10;21(2):313–37.
Lee, Chen-Ting, et al. “Imaging tumor hypoxia to advance radiation oncology.Antioxid Redox Signal, vol. 21, no. 2, July 2014, pp. 313–37. Pubmed, doi:10.1089/ars.2013.5759.
Lee C-T, Boss M-K, Dewhirst MW. Imaging tumor hypoxia to advance radiation oncology. Antioxid Redox Signal. 2014 Jul 10;21(2):313–337.
Journal cover image

Published In

Antioxid Redox Signal

DOI

EISSN

1557-7716

Publication Date

July 10, 2014

Volume

21

Issue

2

Start / End Page

313 / 337

Location

United States

Related Subject Headings

  • Radiation Oncology
  • Neoplasms
  • Molecular Imaging
  • Humans
  • Cell Hypoxia
  • Biochemistry & Molecular Biology
  • 3205 Medical biochemistry and metabolomics
  • 3101 Biochemistry and cell biology
  • 1115 Pharmacology and Pharmaceutical Sciences
  • 1101 Medical Biochemistry and Metabolomics